Sex differences in the metabolism and excretion of nilvadipine, a new dihydropyridine calcium antagonist, in rats

References

• Bäärnhielm C., Backman Ä., Hoffmann K. J., Weidolf L. Biotransformation of felodipine in liver microsomes from rat, dog, and man. Drug Metabolism and Disposition 1986; 14: 613–618
   PubMed Web of Science ®Google Scholar
• Bäärnhielm C., Skänberg I., Borg K. O. Cytochrome P-450-dependent oxidation of felodipine-a 1,4-dihydropyridine to the corresponding pyridine. Xenobiotica 1984; 14: 719–726
   PubMed Web of Science ®Google Scholar
• Böcker R. H., Guengerich F. P. Oxidation of 4-aryl- and 4-alkyl-substituted 2,6-dimethyl-3,5-bis(alkoxycarbonyl)-1,4-dihydropyridines by human liver microsomes and immunochemical evidence for the involvement of a form of cytochrome P-450. Journal of Medical Chemistry 1986; 29: 1596–1603
   PubMed Web of Science ®Google Scholar
• Carter A. L., Stratman F. W. Sex steroid regulation of urinary excretion of carnitine in rats. Journal of Steroid Biochemistry 1982; 17: 211–215
   PubMedGoogle Scholar
• Guengerich F. P. Oxidative cleavage of carboxylic esters by cytochrome P-450. Journal of Biological Chemistry 1987; 262: 8459–8462
   PubMed Web of Science ®Google Scholar
• Guengerich F. P., Martin M. V., Beaune P. H., Kremers P., Wolff T., Waxman D. J. Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. Journal of Biological Chemistry 1986; 261: 5051–5060
   PubMed Web of Science ®Google Scholar
• Hanhijärvi H., Ophaug R. H., Singer L. The sex-related difference in Perfluorooctonoate excretion in the rat (41476). Proceedings of the Society for Experimental Biology and Medicine 1982; 171: 50–55
   PubMed Web of Science ®Google Scholar
• Higushi S., Sasaki H., Shiobara Y., Sado T. Absorption, excretion and metabolism of a new dihydropyridine diester cerebral vasodilator in rats and dogs. Xenobiotica 1977; 7: 469–479
   PubMedGoogle Scholar
• Hoffmann K.-J., Weidolf L. Identification of felodipine metabolites in rat urine. Biomedical Mass Spectrometry 1985; 12: 414–423
   PubMedGoogle Scholar
• Janssen F. W., Young E. M., Ruelius H. W. Effect of sex hormones on the disposition in rats of 1-aminocyclohexane carboxylic acid, a metabolite of a semisynthetic penicillin. Drug Metabolism and Disposition 1976; 4: 540–546
   PubMed Web of Science ®Google Scholar
• Maruhn D., Siefert H. M., Weber H., Rämsch K., Suwelack D. Pharmacokinetics of nimodipine. 1: Communication: Absorption, concentration in plasma and excretion after single administration of (14C)nimodipine in rat, dog and monkey. Arzneimittel-Forschung 1985; 35: 1781–1794
   PubMedGoogle Scholar
• Medenwald H., Schlobmann K., Wänsche C. Strukturaufklärung der renalen Ausscheidungsprodukte von 4-(2′-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsäuredimethylester. Arzneimittel-Forschung 1972; 22: 53–56
   PubMed Web of Science ®Google Scholar
• Meyer H., Sherling D., Karl W. Nitrendipine: Identification and synthesis of main metabolites. Arzneimittel-Forschung 1983b; 33: 1528–1534
   PubMed Web of Science ®Google Scholar
• Meyer H., Wehinger E., Bossert F., Scherling D. Nimodipine: synthesis and metabolic pathway. Arzneimittel-Forschung 1983a; 33: 106–111
   PubMed Web of Science ®Google Scholar
• Niwa T., Tokuma Y., Noguchi H. Oxidation of nilvadipine, a new dihydropyridine calcium antagonist, to the corresponding pyridine by rat liver microsomes. Xenobiotica 1988; 18: 217–224
   PubMed Web of Science ®Google Scholar
• Ohtuka M., Ono T., Hiroi J., Esumi K., Kikuchi H., Kumada S. Journal of Cardiovascular Pharmacology 1983; 5: 1074–1082
   PubMedGoogle Scholar
• Parinov V. J., Odinec A. G., Gilev A. P., Dubur G. J., Muceniece D. H., Ozol J. J., Shatz V. D., Gavars M. P., Vigante B. A. Pharmacokinetics and metabolism of ryodipine in rats. Arzneimittel-Forschung 1985; 35: 808–813
   PubMed Web of Science ®Google Scholar
• Parker S. E., Weinstock J. Biotransformation of 1,4-dihydro-2,6-dimethyl-4-(2-trifluoromethylphenyl)-3,5-pyridine dicarboxylic acid diethyl ester. Journal of Medicinal Chemistry 1973; 16: 34–37
   PubMed Web of Science ®Google Scholar
• Rizzardini M., Smith A. G. Sex differences in the metabolism of hexachlorobenzene by rats and the development of porphyria in females. Biochemical Pharmacology 1982; 31: 3543–3548
   PubMed Web of Science ®Google Scholar
• Rush W. R., Alexander O., Hall D. J., Cairncross L., Dow R. J., Graham D. J. G. The metabolism of nicardipine hydrochloride in healthy male volunteers. Xenobiotica 1986; 16: 341–349
   PubMed Web of Science ®Google Scholar
• Smith A. G., Francis J. E. Evidence for the active renal secretion of S-pentachlorophenyl-N-acetyl-L-cysteine by female rats. Biochemical Pharmacology 1983; 32: 3797–3801
   PubMed Web of Science ®Google Scholar
• Terakawa M., Tokuma Y., Shishido A., Noguchi H. Pharmacokinetics of nilvadipine in healthy volunteers. Journal of Clinical Pharmacology 1987; 27: 111–117
   PubMed Web of Science ®Google Scholar
• Terashita S., Tokuma Y., Fujiwara T., Shiokawa Y., Okumura K., Noguchi H. Metabolism of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs. Xenobiotica 1987; 17: 1415–1425
   PubMed Web of Science ®Google Scholar
• Tokuma Y., Fujiwara T., Noguchi H. Absorption, distribution and excretion of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs. Xenobiotica 1987; 17: 1341–1349
   PubMed Web of Science ®Google Scholar
• Tokuma Y., Sekiguchi M., Niwa T., Noguchi H. Pharmacokinetics of nilvadipine, a new dihydropyridine calcium antagonist, in mice, rats, rabbits and dogs. Xenobiotica 1988; 18: 21–28
   PubMed Web of Science ®Google Scholar
• Walkenstein S. S., Intoccia A. P., Flanagan T. L., Hwang B., Flint D., Weinstock J., Villani A. J., Blackburn D., Green H. Metabolism of the antihypertensive agent 1,4-dihydro-2,6-dimethyl-4-(2-trifluoromethylphenyl)-3,5-pyridine dicarboxylic acid diethyl ester. Journal of Pharmaceutical Sciences 1973; 62: 580–584
   PubMed Web of Science ®Google Scholar
• Weidolf L., Borg K. O., Hoffmann K.-J. Urinary metabolites of felodipine, a new vasodilator drug, in man, dog, rat and mouse. Xenobiotica 1984; 14: 657–666
   PubMed Web of Science ®Google Scholar